These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20338823)

  • 21. Afterword: five steps to increase the payoff of chronic pain trials.
    Max MB
    Neurology; 2005 Dec; 65(12 Suppl 4):S74-7. PubMed ID: 16385108
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capsaicin--an effective topical treatment in pain.
    Markovits E; Gilhar A
    Int J Dermatol; 1997 Jun; 36(6):401-4. PubMed ID: 9248881
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.
    Shaibani A; Biton V; Rauck R; Koch B; Simpson J
    Eur J Pain; 2009 May; 13(5):458-63. PubMed ID: 18619874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregabaline (Lyrica) as a new medication for the treatment of peripheral neuropathic pain].
    Sculier JP
    Rev Med Brux; 2006; 27(6):S529; author reply S529. PubMed ID: 17256424
    [No Abstract]   [Full Text] [Related]  

  • 28. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
    Zakrzewska JM; Cohen J; Brown J; Alksne J; Gemillion H; Linskey M; Sirois D; Pollock B
    Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16685762
    [No Abstract]   [Full Text] [Related]  

  • 29. Methodological issues associated with clinical trials in neuropathic pain.
    Gilron I
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1399-1402. PubMed ID: 27659719
    [No Abstract]   [Full Text] [Related]  

  • 30. [Symptomatic treatment of painful diabetic neuropathies].
    Luft D
    Internist (Berl); 1999 Feb; 40(2):140-7. PubMed ID: 10097971
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and tolerability of pregabalin in patients with neuropathic pain. Observational study under clinical practice conditions].
    Mallison R; Tilke C; Brasser M; Pittrow D
    MMW Fortschr Med; 2007 Apr; 149(14):46. PubMed ID: 17668764
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis, prevention and pain relief in diabetic neuropathy. Tricyclic antidepressive agents or antiepileptic agents can relieve the symptoms].
    Samuelsson H; Solders G; Sundkvist G
    Lakartidningen; 2003 Mar; 100(13):1130-5. PubMed ID: 12705156
    [No Abstract]   [Full Text] [Related]  

  • 33. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic window for amitriptyline analgesia.
    Watson CP
    Can Med Assoc J; 1984 Jan; 130(2):105-6. PubMed ID: 6692187
    [No Abstract]   [Full Text] [Related]  

  • 35. Determining a minimum clinically important difference between treatments for a patient-reported outcome.
    Kirby S; Chuang-Stein C; Morris M
    J Biopharm Stat; 2010 Sep; 20(5):1043-54. PubMed ID: 20721790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical handling of drop-outs in longitudinal clinical trials.
    Harris RI
    Stat Med; 1993 Dec; 12(23):2248-50. PubMed ID: 8310194
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum Toxin Treatment of Neuropathic Pain.
    Mittal SO; Safarpour D; Jabbari B
    Semin Neurol; 2016 Feb; 36(1):73-83. PubMed ID: 26866499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the drug treatment of neuropathic pain. Part 2: antiepileptics and other drugs.
    Drug Ther Bull; 2012 Nov; 50(11):126-9. PubMed ID: 23154593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
    Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.